Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burcelin, R.
Right arrow Articles by Thorens, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burcelin, R.
Right arrow Articles by Thorens, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:1282-1289, 2001
© 2001 by the American Diabetes Association, Inc.

Evidence That Extrapancreatic GLUT2-Dependent Glucose Sensors Control Glucagon Secretion

Rémy Burcelin, and Bernard Thorens

Institute of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland

GLUT2-/- mice reexpressing GLUT1 or GLUT2 in their ß-cells (RIPGLUT1 x GLUT2-/- or RIPGLUT2 x GLUT2-/- mice) have nearly normal glucose-stimulated insulin secretion but show high glucagonemia in the fed state. Because this suggested impaired control of glucagon secretion, we set out to directly evaluate the control of glucagonemia by variations in blood glucose concentrations. Using fasted RIPGLUT1 x GLUT2-/- mice, we showed that glucagonemia was no longer increased by hypoglycemic (2.5 mmol/l glucose) clamps or suppressed by hyperglycemic (10 and 20 mmol/l glucose) clamps. However, an increase in plasma glucagon levels was detected when glycemia was decreased to <=1 mmol/l, indicating preserved glucagon secretory ability, but of reduced sensitivity to glucopenia. To evaluate whether the high-fed glucagonemia could be due to an abnormally increased tone of the autonomic nervous system, fed mutant mice were injected with the ganglionic blockers hexamethonium and chlorisondamine. Both drugs lead to a rapid return of glucagonemia to the levels found in control fed mice. We conclude that 1) in the absence of GLUT2, there is an impaired control of glucagon secretion by low or high glucose; 2) this impaired glucagon secretory activity cannot be due to absence of GLUT2 from {alpha}-cells because these cells do not normally express this transporter; 3) this dysregulation may be due to inactivation of GLUT2-dependent glucose sensors located outside the endocrine pancreas and controlling glucagon secretion; and 4) because fed hyperglucagonemia is rapidly reversed by ganglionic blockers, this suggests that in the absence of GLUT2, there is an increased activity of the autonomic nervous system stimulating glucagon secretion during the fed state.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PhysiologyHome page
N. Marty, M. Dallaporta, and B. Thorens
Brain Glucose Sensing, Counterregulation, and Energy Homeostasis
Physiology, August 1, 2007; 22(4): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Marty, I. Bady, and B. Thorens
Distinct Classes of Central GLUT2-Dependent Sensors Control Counterregulation and Feeding
Diabetes, December 1, 2006; 55(Supplement_2): S108 - S113.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Bady, N. Marty, M. Dallaporta, M. Emery, J. Gyger, D. Tarussio, M. Foretz, and B. Thorens
Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding.
Diabetes, April 1, 2006; 55(4): 988 - 995.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Takahashi, H. Ishihara, A. Tamura, S. Yamaguchi, T. Yamada, D. Takei, H. Katagiri, H. Endou, and Y. Oka
Cell type-specific activation of metabolism reveals that {beta}-cell secretion suppresses glucagon release from {alpha}-cells in rat pancreatic islets
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E308 - E316.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. Bertelli and M. Bendayan
Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development?
J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. Sandu, K. Song, W. Cai, F. Zheng, J. Uribarri, and H. Vlassara
Insulin Resistance and Type 2 Diabetes in High-Fat-Fed Mice Are Linked to High Glycotoxin Intake
Diabetes, August 1, 2005; 54(8): 2314 - 2319.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Franklin, J. Gromada, A. Gjinovci, S. Theander, and C. B. Wollheim
{beta}-Cell Secretory Products Activate {alpha}-Cell ATP-Dependent Potassium Channels to Inhibit Glucagon Release
Diabetes, June 1, 2005; 54(6): 1808 - 1815.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson
Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis
Diabetes, June 1, 2004; 53(6): 1488 - 1495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.